Yumeng Mao Selected Research

Lung Neoplasms (Lung Cancer)

1/2021

Phosphodiesterase 4A confers resistance to PGE2-mediated suppression in CD25+ /CD54+ NK cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yumeng Mao Research Topics

Disease

16	Neoplasms (Cancer) 01/2021 - 05/2010
4	Melanoma (Melanoma, Malignant) 01/2021 - 07/2013
3	Breast Neoplasms (Breast Cancer) 11/2013 - 03/2012
2	Ovarian Neoplasms (Ovarian Cancer) 08/2020 - 01/2020
2	Neuroblastoma 01/2016 - 01/2016
1	Lung Neoplasms (Lung Cancer) 01/2021
1	Adenocarcinoma of Lung 01/2021
1	Squamous Cell Carcinoma of Head and Neck 01/2021
1	Tics (Tic) 08/2020
1	Ascites 08/2020
1	Bites and Stings (Sting) 01/2020
1	Porcine Reproductive and Respiratory Syndrome (PRRS) 01/2020
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2016
1	Ataxia Telangiectasia (Louis Bar Syndrome) 03/2012

Drug/Important Bio-Agent (IBA)

3	Dinoprostone (PGE2)FDA Link 01/2021 - 07/2013
3	Blocking AntibodiesIBA 08/2020 - 01/2016
2	Interleukin-15 (Interleukin 15)IBA 01/2021 - 01/2016
2	Immune Checkpoint InhibitorsIBA 08/2020 - 01/2020
2	Proteins (Proteins, Gene)FDA Link 01/2020 - 05/2010
2	4- (2- (2- hydroxycyclohexylamino)benzothiazol- 6- yloxy)pyridine- 2- carboxylic acid methylamideIBA 01/2016 - 01/2016
2	Macrophage Colony-Stimulating FactorIBA 01/2016 - 01/2016
2	HLA-DR Antigens (HLA-DR)IBA 08/2014 - 07/2013
1	PlatinumIBA 01/2021
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2021
1	Prostaglandin-E SynthasesIBA 01/2021
1	CytokinesIBA 01/2021
1	Interleukin-2 (IL2)IBA 01/2021
1	Cisplatin (Platino)FDA LinkGeneric 01/2021
1	NivolumabIBA 08/2020
1	MethyltransferasesIBA 08/2020
1	A-Form DNA (A-DNA)IBA 08/2020
1	Toll-Like Receptor AgonistsIBA 01/2020
1	Pharmaceutical PreparationsIBA 01/2020
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2020
1	Pattern Recognition ReceptorsIBA 01/2020
1	NLR ProteinsIBA 01/2020
1	Therapeutic UsesIBA 01/2016
1	ChemokinesIBA 01/2016
1	VaccinesIBA 06/2015
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 08/2014
1	Biomarkers (Surrogate Marker)IBA 03/2014
1	Amino Acids FDA Link 11/2013
1	Phenobarbital (Luminal)FDA Link 11/2013
1	Immune Checkpoint ProteinsIBA 09/2013
1	IpilimumabIBA 09/2013
1	Superoxides (Superoxide)IBA 07/2013
1	ArginaseIBA 11/2012
1	EnzymesIBA 11/2012
1	ErbB Receptors (EGF Receptor)IBA 10/2012
1	Caffeine (No Doz)FDA LinkGeneric 03/2012
1	LigandsIBA 03/2012
1	Protein Kinases (Protein Kinase)IBA 03/2012
1	MHC class I-related chain AIBA 03/2012
1	Phosphotransferases (Kinase)IBA 03/2012
1	tyrosine receptor (receptor, tyrosine)IBA 03/2012
1	micaIBA 03/2012
1	NeuregulinsIBA 03/2012
1	AntibodiesIBA 05/2010

Therapy/Procedure

7	Immunotherapy 01/2021 - 05/2010
4	Therapeutics 08/2020 - 03/2014
1	Drug Therapy (Chemotherapy) 08/2020
1	Combined Modality Therapy 01/2016